Literature DB >> 17962914

[Brain stimulation methods for resistance to therapy].

T E Schläpfer1.   

Abstract

In psychiatry there is growing awareness of the urgent need for treatment of patients with severe depression who are refractory to treatment. While highly efficacious over its nearly 70-year history, electroconvulsive treatment is tainted with two basic disadvantages: high relapse quotas and sometimes extensive cognitive side effects. Therefore novel methods of brain stimulation are being employed: transcranial magnetic stimulation, magnetic seizure stimulation, vagus nerve stimulation, and deep brain stimulation. These four techniques are used in individual cases but still outside the framework of scientific research studies. Their clinical effects and effectivity require further definition. This paper reports the current status of brain stimulation methods and describes possible further developments.

Entities:  

Mesh:

Year:  2007        PMID: 17962914     DOI: 10.1007/s00115-007-2371-4

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  20 in total

1.  Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis.

Authors:  Tal Burt; Sarah H Lisanby; Harold A Sackeim
Journal:  Int J Neuropsychopharmacol       Date:  2002-03       Impact factor: 5.176

2.  Deep brain stimulation for treatment-resistant depression.

Authors:  Helen S Mayberg; Andres M Lozano; Valerie Voon; Heather E McNeely; David Seminowicz; Clement Hamani; Jason M Schwalb; Sidney H Kennedy
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

3.  Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996.

Authors:  E M Wassermann
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1998-01

4.  Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.

Authors:  H A Sackeim; A J Rush; M S George; L B Marangell; M M Husain; Z Nahas; C R Johnson; S Seidman; C Giller; S Haines; R K Simpson; R R Goodman
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

Review 5.  Transcranial magnetic stimulation for depression and other psychiatric disorders.

Authors:  B McNamara; J L Ray; O J Arthurs; S Boniface
Journal:  Psychol Med       Date:  2001-10       Impact factor: 7.723

6.  A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.

Authors:  Mark S George; A John Rush; Lauren B Marangell; Harold A Sackeim; Stephen K Brannan; Sonia M Davis; Robert Howland; Mitchel A Kling; Francisco Moreno; Barry Rittberg; David Dunner; Thomas Schwartz; Linda Carpenter; Michael Burke; Philip Ninan; Paul Goodnick
Journal:  Biol Psychiatry       Date:  2005-09-01       Impact factor: 13.382

7.  Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.

Authors:  A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; Andrew A Nierenberg; Jonathan W Stewart; Diane Warden; George Niederehe; Michael E Thase; Philip W Lavori; Barry D Lebowitz; Patrick J McGrath; Jerrold F Rosenbaum; Harold A Sackeim; David J Kupfer; James Luther; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

8.  Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy.

Authors:  Sarah H Lisanby; Bruce Luber; Thomas E Schlaepfer; Harold A Sackeim
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

9.  Vagus nerve stimulation for depression: efficacy and safety in a European study.

Authors:  T E Schlaepfer; C Frick; A Zobel; W Maier; I Heuser; M Bajbouj; V O'Keane; C Corcoran; R Adolfsson; M Trimble; H Rau; H-J Hoff; F Padberg; F Müller-Siecheneder; K Audenaert; D Van den Abbeele; K Matthews; D Christmas; Z Stanga; M Hasdemir
Journal:  Psychol Med       Date:  2008-01-04       Impact factor: 7.723

10.  Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression.

Authors:  Thomas E Schlaepfer; Michael X Cohen; Caroline Frick; Markus Kosel; Daniela Brodesser; Nikolai Axmacher; Alexius Young Joe; Martina Kreft; Doris Lenartz; Volker Sturm
Journal:  Neuropsychopharmacology       Date:  2007-04-11       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.